Clarke Neumann - 15 Mar 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Senior Vice President, General Counsel and Secretary
Signature
/s/ Will Pridgen, Attorney-in-Fact for Clarke Neumann
Issuer symbol
BIORQ
Transactions as of
15 Mar 2023
Net transactions value
-$27,348
Form type
4
Filing time
17 Mar 2023, 21:21:39 UTC
Previous filing
17 Feb 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +57,950 +268% $0.000000 79,568 15 Mar 2023 Direct F1
transaction BIOR Common Stock Award $0 +21,684 +27% $0.000000 101,252 15 Mar 2023 Direct F2
transaction BIOR Common Stock Tax liability $27,348 -10,683 -11% $2.56 90,569 15 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 57,950 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
F2 Consists of 21,684 RSUs, which vested upon grant.
F3 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.

Remarks:

Senior Vice President, General Counsel and Secretary